These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2903237

  • 1. Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals.
    Maura G, Giardi A, Raiteri M.
    J Pharmacol Exp Ther; 1988 Nov; 247(2):680-4. PubMed ID: 2903237
    [Abstract] [Full Text] [Related]

  • 2. Aspartate-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of release.
    Maura G, Carbone R, Raiteri M.
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1142-6. PubMed ID: 2574740
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A, Tanda G, Frau R, Di Chiara G.
    J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
    [Abstract] [Full Text] [Related]

  • 4. Biphasic modulation of evoked [3H]D-aspartate release by D-2 dopamine receptors in rat striatal slices.
    Peris J, Dwoskin LP, Zahniser NR.
    Synapse; 1988 Apr; 2(4):450-6. PubMed ID: 2973144
    [Abstract] [Full Text] [Related]

  • 5. Modulation of the Ca++-evoked release of [3H]dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists.
    Bowyer JF, Weiner N.
    J Pharmacol Exp Ther; 1987 Apr; 241(1):27-33. PubMed ID: 3572788
    [Abstract] [Full Text] [Related]

  • 6. D-2 dopamine receptors inhibit release of aspartate and glutamate in rat retina.
    Kamisaki Y, Hamahashi T, Mita C, Itoh T.
    J Pharmacol Exp Ther; 1991 Feb; 256(2):634-8. PubMed ID: 1671598
    [Abstract] [Full Text] [Related]

  • 7. Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors.
    Dwoskin LP, Zahniser NR.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):442-53. PubMed ID: 3772803
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
    Calabresi P, Mercuri NB, Sancesario G, Bernardi G.
    Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
    [Abstract] [Full Text] [Related]

  • 9. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P, Abercrombie ED.
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [Abstract] [Full Text] [Related]

  • 10. Alpha 2-adrenoceptors are not involved in the regulation of striatal glutamate release: comparison to dopaminergic inhibition.
    Harsing LG, Vizi ES.
    J Neurosci Res; 1991 Mar; 28(3):376-81. PubMed ID: 1677428
    [Abstract] [Full Text] [Related]

  • 11. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK, Manzino L, Heikkila RE.
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [Abstract] [Full Text] [Related]

  • 12. SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons.
    Kelland MD, Freeman AS, Chiodo LA.
    Synapse; 1988 Oct; 2(4):416-23. PubMed ID: 2973142
    [Abstract] [Full Text] [Related]

  • 13. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.
    Arnt J, Hyttel J.
    Psychopharmacology (Berl); 1985 Oct; 85(3):346-52. PubMed ID: 2860689
    [Abstract] [Full Text] [Related]

  • 14. D-1 receptor-linked mechanism modulates cholinergic neurotransmission in rat striatum.
    Consolo S, Wu CF, Fusi R.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):300-5. PubMed ID: 2886638
    [Abstract] [Full Text] [Related]

  • 15. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
    Robertson GS, Tham CS, Wilson C, Jakubovic A, Fibiger HC.
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550
    [Abstract] [Full Text] [Related]

  • 16. Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+-stimulated release of acetylcholine from rat neostriatum.
    Stoof JC, Kebabian JW.
    Brain Res; 1982 Nov 04; 250(2):263-70. PubMed ID: 6293642
    [Abstract] [Full Text] [Related]

  • 17. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May 04; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 18. Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.
    Hoffmann IS, Talmaciu RK, Ferro CP, Cubeddu LX.
    J Pharmacol Exp Ther; 1988 Jun 04; 245(3):761-72. PubMed ID: 3385641
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effects of amphetamine on potassium-stimulated release of [3H]dopamine from striatal slices and synaptosomes.
    Bowyer JF, Masserano JM, Weiner N.
    J Pharmacol Exp Ther; 1987 Jan 04; 240(1):177-86. PubMed ID: 3100768
    [Abstract] [Full Text] [Related]

  • 20. Stimulation of dopamine receptors inhibited Ca2+-calmodulin-dependent protein kinase II activity in rat striatal slices.
    Hou XY, Tang FM, Zhang GY.
    Acta Pharmacol Sin; 2001 Nov 04; 22(11):966-70. PubMed ID: 11749784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.